The combination of ursolic acid and leucine potentiates the differentiation of C2C12 murine myoblasts through the mTOR signaling pathway

Kim,Minjung; Sung,Bokyung; Kang,Yong  Jung; Kim,Dong  Hwan; Lee,Yujin; Hwang,Seong  Yeon; Yoon,Jeong-Hyun; Yoo,Mi-Ae; Kim,Cheol  Min; Chung,Hae  Young; Kim,Nam  Deuk

doi:10.3892/ijmm.2014.2046

The combination of ursolic acid and leucine potentiates the differentiation of C2C12 murine myoblasts through the mTOR signaling pathway

Authors:
- Minjung Kim
- Bokyung Sung
- Yong Jung Kang
- Dong Hwan Kim
- Yujin Lee
- Seong Yeon Hwang
- Jeong-Hyun Yoon
- Mi-Ae Yoo
- Cheol Min Kim
- Hae Young Chung
- Nam Deuk Kim
View Affiliations

Affiliations: Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 609‑735, Republic of Korea, Department of Molecular Biology, Pusan National University, Busan 609‑735, Republic of Korea, Research Center for Anti‑Aging Technology Development, Pusan National University, Busan 609‑735, Republic of Korea
Published online on: December 22, 2014 https://doi.org/10.3892/ijmm.2014.2046
Pages: 755-762

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aging causes phenotypic changes in skeletal muscle progenitor cells that lead to the progressive loss of myogenic differentiation and thus a decrease in muscle mass. The naturally occurring triterpene, ursolic acid, has been reported to be an effective agent for the prevention of muscle loss by suppressing degenerative muscular dystrophy. Leucine, a branched-chain amino acid, and its metabolite, β-hydroxy-β-methylbutyric acid, have been reported to enhance protein synthesis in skeletal muscle. Therefore, the aim of the present study was to investigate whether the combination of ursolic acid and leucine promotes greater myogenic differentiation compared to either agent alone in C2C12 murine myoblasts. Morphological changes were observed and creatine kinase (CK) activity analysis was performed to determine the conditions through which the combination of ursolic acid and leucine would exert the most prominent effects on muscle cell differentiation. The effect of the combination of ursolic acid and leucine on the expression of myogenic differentiation marker genes was examined by RT-PCR and western blot analysis. The combination of ursolic acid (0.5 µM) and leucine (10 µM) proved to be the most effective in promoting myogenic differentiation. The combination of ursolic acid and leucine significantly increased CK activity than treatment with either agent alone. The level of myosin heavy chain, a myogenic differentiation marker protein, was also enhanced by the combination of ursolic acid and leucine. The combination of ursolic acid and leucine significantly induced the expression of myogenic differentiation marker genes, such as myogenic differentiation 1 (MyoD) and myogenin, at both the mRNA and protein level. In addition, the number of myotubes and the fusion index were increased. These findings indicate that the combination of ursolic acid and leucine promotes muscle cell differentiation, thus suggesting that this combination of agents may prove to be beneficial in increasing muscle mass.

View Figures

View References

1	Dedieu S, Mazeres G, Cottin P and Brustis JJ: Involvement of myogenic regulator factors during fusion in the cell line C2C12. Int J Dev Biol. 46:235–241. 2002.PubMed/NCBI
2	Doherty JT, Lenhart KC, Cameron MV, Mack CP, Conlon FL and Taylor JM: Skeletal muscle differentiation and fusion are regulated by the BAR-containing Rho-GTPase-activating protein (Rho-GAP), GRAF1. J Biol Chem. 286:25903–25921. 2011. View Article : Google Scholar : PubMed/NCBI
3	Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH and Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1351–1359. 1993. View Article : Google Scholar : PubMed/NCBI
4	Kablar B, Krastel K, Ying C, Asakura A, Tapscott SJ and Rudnicki MA: MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development. 124:4729–4738. 1997.
5	Ishibashi J, Perry RL, Asakura A and Rudnicki MA: MyoD induces myogenic differentiation through cooperation of its NH2-and COOH-terminal regions. J Cell Biol. 171:471–482. 2005. View Article : Google Scholar : PubMed/NCBI
6	Naidu PS, Ludolph DC, To RQ, Hinterberger TJ and Konieczny SF: Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol Cell Biol. 15:2707–2718. 1995.PubMed/NCBI
7	Liu J: Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 49:57–68. 1995. View Article : Google Scholar : PubMed/NCBI
8	Jager S, Trojan H, Kopp T, Laszczyk MN and Scheffler A: Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts. Molecules. 14:2016–2031. 2009. View Article : Google Scholar : PubMed/NCBI
9	Leng S, Hao Y, Du D, et al: Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. Int J Cancer. 133:2781–2790. 2013.PubMed/NCBI
10	Zhang W, Hong D, Zhou Y, et al: Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta. 1760:1505–1512. 2006. View Article : Google Scholar : PubMed/NCBI
11	Wilkinson K, Boyd JD, Glicksman M, Moore KJ and El Khoury J: A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36. J Biol Chem. 286:34914–34922. 2011. View Article : Google Scholar : PubMed/NCBI
12	He Y, Li Y, Zhao T, Wang Y and Sun C: Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One. 8:e701352013. View Article : Google Scholar : PubMed/NCBI
13	Jung SH, Ha YJ, Shim EK, et al: Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem J. 403:243–250. 2007. View Article : Google Scholar : PubMed/NCBI
14	Kunkel SD, Suneja M, Ebert SM, et al: mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 13:627–638. 2011. View Article : Google Scholar : PubMed/NCBI
15	Kunkel SD, Elmore CJ, Bongers KS, et al: Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 7:e393322012. View Article : Google Scholar : PubMed/NCBI
16	She P, Olson KC, Kadota Y, et al: Leucine and protein metabolism in obese Zucker rats. PLoS One. 8:e594432013. View Article : Google Scholar : PubMed/NCBI
17	Haegens A, Schols AM, van Essen AL, van Loon LJ and Langen RC: Leucine induces myofibrillar protein accretion in cultured skeletal muscle through mTOR dependent and -independent control of myosin heavy chain mRNA levels. Mol Nutr Food Res. 56:741–752. 2012. View Article : Google Scholar : PubMed/NCBI
18	Fitschen PJ, Wilson GJ, Wilson JM and Wilund KR: Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in elderly and clinical populations. Nutrition. 29:29–36. 2013. View Article : Google Scholar
19	Nissen S, Sharp RL, Panton L, Vukovich M, Trappe S and Fuller JC Jr: beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 130:1937–1945. 2000.PubMed/NCBI
20	Salles J, Chanet A, Giraudet C, et al: 1,25(OH)₂-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes. Mol Nutr Food Res. 57:2137–2146. 2013. View Article : Google Scholar : PubMed/NCBI
21	Alway SE, Pereira SL, Edens NK, Hao Y and Bennett BT: beta-Hydroxy-beta-methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of aged rats during recovery from disuse atrophy. Exp Gerontol. 48:973–984. 2013. View Article : Google Scholar : PubMed/NCBI
22	Pereira MG, Baptista IL, Carlassara EO, Moriscot AS, Aoki MS and Miyabara EH: Leucine supplementation improves skeletal muscle regeneration after cryolesion in rats. PLoS One. 9:e852832014. View Article : Google Scholar : PubMed/NCBI
23	Zhou H and Huang S: The complexes of mammalian target of rapamycin. Curr Protein Pept Sci. 11:409–424. 2010. View Article : Google Scholar : PubMed/NCBI
24	Teleman AA, Chen YW and Cohen SM: 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev. 19:1844–1848. 2005. View Article : Google Scholar : PubMed/NCBI
25	Miron M, Verdú J, Lachance PE, Birnbaum MJ, Lasko PF and Sonenberg N: The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nat Cell Biol. 3:596–601. 2001. View Article : Google Scholar : PubMed/NCBI
26	Ding M, Xie Y, Wagner RJ, et al: Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol. 31:1403–1410. 2011. View Article : Google Scholar : PubMed/NCBI
27	Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C and Avruch J: Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem. 273:14484–14494. 1998. View Article : Google Scholar : PubMed/NCBI
28	Proud CG: mTOR-mediated regulation of translation factors by amino acids. Biochem Biophys Res Commun. 313:429–436. 2004. View Article : Google Scholar
29	Lian J, Yan XH, Peng J and Jiang SW: The mammalian target of rapamycin pathway and its role in molecular nutrition regulation. Mol Nutr Food Res. 52:393–399. 2008. View Article : Google Scholar : PubMed/NCBI
30	Burnett PE, Barrow RK, Cohen NA, Snyder SH and Sabatini DM: RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci USA. 95:1432–1437. 1998. View Article : Google Scholar : PubMed/NCBI
31	Vinciguerra M, Musaro A and Rosenthal N: Regulation of muscle atrophy in aging and disease. Adv Exp Med Biol. 694:211–233. 2010. View Article : Google Scholar : PubMed/NCBI
32	Averous J, Gabillard JC, Seiliez I and Dardevet D: Leucine limitation regulates myf5 and myoD expression and inhibits myoblast differentiation. Exp Cell Res. 318:217–227. 2012. View Article : Google Scholar
33	Ogasawara R, Sato K, Higashida K, Nakazato K and Fujita S: Ursolic acid stimulates mTORC1 signaling after resistance exercise in rat skeletal muscle. Am J Physiol Endocrinol Metab. 305:E760–E765. 2013. View Article : Google Scholar : PubMed/NCBI
34	Kablar B, Krastel K, Tajbakhsh S and Rudnicki MA: Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Dev Biol. 258:307–318. 2003. View Article : Google Scholar : PubMed/NCBI
35	Myer A, Olson EN and Klein WH: MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev Biol. 229:340–350. 2001. View Article : Google Scholar : PubMed/NCBI
36	Meadows E, Cho JH, Flynn JM and Klein WH: Myogenin regulates a distinct genetic program in adult muscle stem cells. Dev Biol. 322:406–414. 2008. View Article : Google Scholar : PubMed/NCBI
37	Breitschopf K, Bengal E, Ziv T, Admon A and Ciechanover A: A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 17:5964–5973. 1998. View Article : Google Scholar : PubMed/NCBI
38	Sartorelli V, Puri PL, Hamamori Y, et al: Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell. 4:725–734. 1999. View Article : Google Scholar
39	Jo C, Cho SJ and Jo SA: Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation. J Biol Chem. 286:18903–18913. 2011. View Article : Google Scholar : PubMed/NCBI
40	Ling BM, Bharathy N, Chung TK, et al: Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci USA. 109:841–846. 2012. View Article : Google Scholar : PubMed/NCBI
41	Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V and Nadal-Ginard B: Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:309–324. 1993. View Article : Google Scholar : PubMed/NCBI
42	Zhang JM, Wei Q, Zhao X and Paterson BM: Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J. 18:926–933. 1999. View Article : Google Scholar : PubMed/NCBI
43	Yang H, Li F, Kong X, et al: Chemerin regulates proliferation and differentiation of myoblast cells via ERK1/2 and mTOR signaling pathways. Cytokine. 60:646–652. 2012. View Article : Google Scholar : PubMed/NCBI